New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Lorus Therapeutics (LRP)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
29-FEB
2012
31-MAY
2012
31-AUG
2012
30-NOV
2012
28-FEB
2013
Total Revenue
0
0
0
0
0
Cost of Revenue
-8000
0
0
0
0
Gross Profit
8000
0
0
0
0
Research & Development
543K
212K
623K
845K
823K
SG&A
476K
748K
630K
770K
548K
Amortization & Deprec
11.0K
11.0K
10.0K
9000
9000
Other Expenses
-2000
-188K
-6000
-11.0K
-9000
Total Operating Expenses
1.03M
783K
1.26M
1.61M
1.37M
Operating Income
-1.02M
-783K
-1.26M
-1.61M
-1.37M
Other Income
0
-213K
0
0
0
EBIT
-1.02M
-996K
-1.26M
-1.61M
-1.37M
Minority Interest
0
0
0
0
0
Interest Expense
3000
17.0K
6000
0
0
Income Before Taxes
-1.02M
-1.01M
-1.26M
-1.61M
-1.37M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-1.02M
-1.01M
-1.26M
-1.61M
-1.37M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-1.02M
-1.01M
-1.26M
-1.61M
-1.37M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-1.02M
-1.01M
-1.26M
-1.61M
-1.37M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour